Endotracheal Intubation Devices

NCT ID: NCT02277652

Last Updated: 2014-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to compare the four different intubation devices in 6 different scenarios.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intubation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Scenario 1: Uninterrupted chest compressions

Endotracheal intubation (ETI) during pediatric manikin with uninterrupted chest compressions. Chest compression was performed using LUCAS-2 (Physio-Control, USA).

Group Type EXPERIMENTAL

The Miller Laryngoscope

Intervention Type DEVICE

Direct laryngoscopy

The Bonfils intubation fibrescope

Intervention Type DEVICE

Optical laryngoscopy

The GlideScope Ranger

Intervention Type DEVICE

Videolaryngoscopy

The Supraglottic Airway Laryngopharyngeal Tube (SALT)

Intervention Type DEVICE

Blind intubation

Scenario 2: Neutral position

ETI performed in neutral mannikin head position

Group Type EXPERIMENTAL

The Miller Laryngoscope

Intervention Type DEVICE

Direct laryngoscopy

The Bonfils intubation fibrescope

Intervention Type DEVICE

Optical laryngoscopy

The GlideScope Ranger

Intervention Type DEVICE

Videolaryngoscopy

The Supraglottic Airway Laryngopharyngeal Tube (SALT)

Intervention Type DEVICE

Blind intubation

Scenario 3: Sniffing position

ETI performed in sniffing mannikin head position

Group Type EXPERIMENTAL

The Miller Laryngoscope

Intervention Type DEVICE

Direct laryngoscopy

The Bonfils intubation fibrescope

Intervention Type DEVICE

Optical laryngoscopy

The GlideScope Ranger

Intervention Type DEVICE

Videolaryngoscopy

The Supraglottic Airway Laryngopharyngeal Tube (SALT)

Intervention Type DEVICE

Blind intubation

Scenario 4: Pharyngeal swelling

ETI performed during mannikin pharyngeal swelling scenario

Group Type EXPERIMENTAL

The Miller Laryngoscope

Intervention Type DEVICE

Direct laryngoscopy

The Bonfils intubation fibrescope

Intervention Type DEVICE

Optical laryngoscopy

The GlideScope Ranger

Intervention Type DEVICE

Videolaryngoscopy

The Supraglottic Airway Laryngopharyngeal Tube (SALT)

Intervention Type DEVICE

Blind intubation

Scenario 5: Swollen tongue

ETI performed during mannikin swollen tongue scenario

Group Type EXPERIMENTAL

The Miller Laryngoscope

Intervention Type DEVICE

Direct laryngoscopy

The Bonfils intubation fibrescope

Intervention Type DEVICE

Optical laryngoscopy

The GlideScope Ranger

Intervention Type DEVICE

Videolaryngoscopy

The Supraglottic Airway Laryngopharyngeal Tube (SALT)

Intervention Type DEVICE

Blind intubation

Scenario 6: Immobilized cervical spine

ETI performed during mannikin immobilized cervical spine scenario

Group Type EXPERIMENTAL

The Miller Laryngoscope

Intervention Type DEVICE

Direct laryngoscopy

The Bonfils intubation fibrescope

Intervention Type DEVICE

Optical laryngoscopy

The GlideScope Ranger

Intervention Type DEVICE

Videolaryngoscopy

The Supraglottic Airway Laryngopharyngeal Tube (SALT)

Intervention Type DEVICE

Blind intubation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The Miller Laryngoscope

Direct laryngoscopy

Intervention Type DEVICE

The Bonfils intubation fibrescope

Optical laryngoscopy

Intervention Type DEVICE

The GlideScope Ranger

Videolaryngoscopy

Intervention Type DEVICE

The Supraglottic Airway Laryngopharyngeal Tube (SALT)

Blind intubation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* give voluntary consent to participate in the study
* minimum 1 year of work experience in emergency medicine
* experienced emergency medical personnel (paramedics, nurses, physicians)

Exclusion Criteria

* not meet the above criteria
* wrist or low back diseases
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

International Institute of Rescue Research and Education

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lukasz Szarpak

Lukasz Szarpak

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lukasz Szarpak

Role: PRINCIPAL_INVESTIGATOR

National Institute of Cardiology, Warsaw, Poland

Andrzej Kurowski

Role: PRINCIPAL_INVESTIGATOR

National Institute of Cardiology, Warsaw, Poland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

International Institute of Rescue Research and Education

Warsaw, Masovia, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lukasz Szarpak

Role: CONTACT

(+48)500186225

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lukasz Szarpak

Role: primary

(+48)500186225

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ETI/2014/03

Identifier Type: -

Identifier Source: org_study_id